These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacological basis of akinesia in Parkinson's disease. Narabayashi H J Neural Transm Suppl; 1983; 19():143-51. PubMed ID: 6583305 [TBL] [Abstract][Full Text] [Related]
7. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy. Grace AA Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673 [TBL] [Abstract][Full Text] [Related]
8. [Thoughts on the neurobiological aspects of Parkinson syndrome]. Sommer H Psychiatr Neurol Med Psychol (Leipz); 1986 Feb; 38(2):86-90. PubMed ID: 3010357 [TBL] [Abstract][Full Text] [Related]
9. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced changes in brain dopamine and their relation to parkinsonism. Vogt M Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923 [No Abstract] [Full Text] [Related]
12. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method. Orzi F; Fornai F; Blandini F Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530 [No Abstract] [Full Text] [Related]
13. [Movement disorders and basal ganglia function]. Dietrichs E Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574 [TBL] [Abstract][Full Text] [Related]
14. Developments in understanding the physiology and pharmacology of parkinsonism. Teräväinen H; Calne DB Acta Neurol Scand; 1979 Jul; 60(1):1-11. PubMed ID: 40381 [TBL] [Abstract][Full Text] [Related]
15. The history of dopamine and levodopa in the treatment of Parkinson's disease. Fahn S Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671 [TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Strange PG Mov Disord; 1993 Jul; 8(3):263-70. PubMed ID: 8101967 [TBL] [Abstract][Full Text] [Related]
17. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis]. Borromei A; Manzini A Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450 [No Abstract] [Full Text] [Related]
18. Three types of akinesia in the progressive course of Parkinson's disease. Narabayashi H Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577 [No Abstract] [Full Text] [Related]
19. Problems arising during chronic treatment with L-dopa for Parkinson's disease: changes in response to treatment. Caraceni TA; Girotti F; Giovannini P; Parati E J Neural Transm Suppl; 1986; 22():189-99. PubMed ID: 3537210 [TBL] [Abstract][Full Text] [Related]